TipRanksStock Market NewsAMEH NewsApollo Medical Holdings (AMEH) Receives a Buy from Colliers Securities

Apollo Medical Holdings (AMEH) Receives a Buy from Colliers Securities

In a report released today, Kyle Bauser from Colliers Securities initiated coverage with a Buy rating on Apollo Medical Holdings (AMEHResearch Report) and a price target of $93.00. The company’s shares closed last Friday at $60.06.

According to TipRanks.com, Bauser is a 2-star analyst with an average return of 0.3% and a 45.5% success rate. Bauser covers the Healthcare sector, focusing on stocks such as Chembio Diagnostics, Semler Scientific, and Motus Gi Holdings.

Apollo Medical Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $93.00.

See the top stocks recommended by analysts >>

Apollo Medical Holdings’ market cap is currently $2.67B and has a P/E ratio of 38.58.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Apollo Medical Holdings, Inc. engages in the provision of healthcare services. It offers integrated care, inpatient, and physician alignment solutions. The company focuses on physicians providing medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The firm operates through the healthcare delivery segment. The healthcare delivery segment implements and operates innovative health care models to create a patient-centered, physician-centric experience. Apollo Medical Holdings was founded on November 1, 1985 and is headquartered in Alhambra, CA.

Read More on AMEH:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More